RNA Disease Diagnostics: Dipanjan Pan, John Erickson

RNA Disease Diagnostics has appointed Dipanjan Pan, its chief scientific advisor, and John Erickson, its president, to the board of directors.

Pan is a professor of diagnostic radiology and nuclear medicine; pediatrics, chemical, biochemical, and environmental engineering; computer science; and electrical engineering at the University of Maryland Baltimore School of Medicine and the University of Maryland Baltimore County. He was previously an associate professor and associate head of the department of bioengineering at the University of Illinois, Urbana-Champaign. Pan's research has resulted in the licensing of a point-of-care biosensor for COVID-19 that RNA Disease Diagnostics is commercializing.

Erickson joined RNA Disease Diagnostics as president in 2021. Previously, he led Erickson Healthcare Consulting, a management and strategy consulting firm he founded in 2017. Before that, Erickson held C-suite and senior executive leadership positions with RapidBio Systems, Johnson & Johnson (LifeScan), Abbott Laboratories, ITC Nexus Dx, and Bio-Rad Laboratories.